Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis
Clinical trial NCT03711448 · COMPLETED
Trial details
- NCT number
- NCT03711448
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2024-09-11
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.